4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000123
Director sold 756 shares at $1,170.00 ($884,520)
- Director acquired 756 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bassler Bonnie L · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +756 | $371.40 | $280,778 | 2,138 | D |
| 2024-08-15 | Sale : show line 2 in the form 10b5-1 | −756 | $1,170.00 | $884,520 | 1,382 | D |
| Open-market sales · 756 sh · avg $1,170.00 · $884,520 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-15 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −756 | 1,516 | D |
Loading xslF345X05/edgardoc.xml…